TAM
ATRA icon

Tocqueville Asset Management’s Atara Biotherapeutics ATRA Stock Holding History

Tocqueville Asset Management’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-877
Closed -$872K – 778
2019
Q1 		$872K Buy
877
+404
+85% +$375K 0.01% 496
2018
Q4 		$411K Buy
473
+40
+9% +$37.1K 0.01% 584
2018
Q3 		$448K Buy
433
+40
+10% +$39.1K 0.01% 640
2018
Q2 		$361K Buy
393
+52
+15% +$55.9K ﹤0.01% 659
2018
Q1 		$332K Buy
+341
New +$311K ﹤0.01% 687
2016
Q1 		– Sell
-460
Closed -$304K – 865
2015
Q4 		$304K Sell
460
-901
-66% -$682K ﹤0.01% 769
2015
Q3 		$1.07M Buy
1,361
+1,101
+423% +$1.34M 0.01% 551
2015
Q2 		$343K Buy
+260
New +$298K ﹤0.01% 808

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return